Fluoxetine Disposition in Patients with Chronic Hepatitis C Treated with Interferon-α

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.11, 2010-11, pp. : 767-772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Carnitine on Biochemical Responses in Patients with Chronic Hepatitis C Treated with Interferon-

By Malaguarnera M.

Clinical Drug Investigation, Vol. 22, Iss. 7, 2002-07 ,pp. : 443-448

Adis International

Access to resources Recommend Favorite

Psychiatric Symptoms Induced by Antiviral Therapy in Chronic Hepatitis C: Comparison between Interferon-α-2a and Interferon-α-2b

By Neri Sergio Pulvirenti Davide Bertino Gaetano

Clinical Drug Investigation, Vol. 26, Iss. 11, 2006-01 ,pp. : 655-662

Adis International

Access to resources Recommend Favorite

Albumin-interferon-α in the treatment of chronic hepatitis C

By Balan Vijayan

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 269-278

Future Medicine

Access to resources Recommend Favorite

Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis C: A Randomized Open-Label Study of Pegylated Interferon-α-2a versus Pegylated Interferon-α-2b

By Scotto Gaetano

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 791-801

Adis International

Access to resources Recommend Favorite

Interferon-α-2b: Steatohepatitis in a patient with chronic hepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1206, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite